achromatopsia

human illness, a type of color blindness

Uses your system voice; voice and rate in settings.

Q432396Snapshot

≈ 4 min read

Names in other languages

  • Englishachromatopsia
  • Françaisachromatopsie
  • Nederlandsachromatopsie
  • caacromatòpsia
  • Españolacromatopsia
  • etAkromatopsia
  • glAcromatopsia
  • Italianoacromatopsia

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Achromatopsia, also known as rod monochromacy, is a medical syndrome that exhibits symptoms relating to five conditions, most notably monochromacy. Historically, the name referred to monochromacy in general, but now typically refers only to an autosomal recessive congenital color vision condition.

The term is also used to describe cerebral achromatopsia, though monochromacy is usually the only common symptom. The conditions include: monochromatic color blindness, poor visual acuity, and day-blindness. The syndrome is also present in an incomplete form that exhibits milder symptoms, including residual color vision.

Achromatopsia is estimated to affect 1 in 30,000 live births worldwide.

Achromatopsia, also known as rod monochromacy, is a medical syndrome that exhibits symptoms relating to five conditions, most notably monochromacy. Historically, the name referred to monochromacy in general, but now typically refers only to an autosomal recessive congenital color vision condition.

The term is also used to describe cerebral achromatopsia, though monochromacy is usually the only common symptom. The conditions include: monochromatic color blindness, poor visual acuity, and day-blindness. The syndrome is also present in an incomplete form that exhibits milder symptoms, including residual color vision.

Achromatopsia is estimated to affect 1 in 30,000 live births worldwide.

Gene therapy

As achromatopsia is linked to only a few single-gene mutations, it is a good candidate for gene therapy. Gene therapy is a technique for injecting functional genes into the cells that need them, replacing or overruling the original alleles linked to achromatopsia, thereby curing it – at least in part.

Achromatopsia has been a focus of gene therapy since 2010, when achromatopsia in dogs was partially cured. Several clinical trials on humans are ongoing with mixed results. In July 2023, a study found positive but limited improvements on congenital CNGA3 achromatopsia.

Eyeborg

Since 2003, a cybernetic device called the eyeborg has allowed people to perceive color through sound waves. This form of sensory substitution maps the hue perceived by a camera worn on the head to a pitch experienced through bone conduction according to a sonochromatic scale. This allows achromats (or even the totally blind) to perceive – or estimate – the color of an object.

Achromat and artist Neil Harbisson was the first to use the eyeborg in early 2004, which allowed him to start painting in color. He has since acted as a spokesperson for the technology, namely in a 2012 TED Talk. A 2015 study suggests that achromats who use the Eyeborg for several years exhibit neural plasticity, which indicates the sensory substitution has become intuitive for them.

Other accommodations

While gene therapy and the Eyeborg may currently have low uptake with achromats, there are several more practical ways for achromats to manage their condition: Some colors can be estimated through the use of colored filters. By comparing the luminosity of a color with and without a filter (or between two different filters), the color can be estimated.

This is the premise of monocular lenses and the SeeKey. In some US states, achromats can use a red filter while driving to determine the color of a traffic light. To alleviate photophobia stemming from hemeralopia, dark red or plum colored filters as either sunglasses or tinted contacts are very helpful at decreasing light sensitivity.

To manage the low visual acuity that is typical of achromatopsia, achromats may use telescopic systems, specifically when driving, to increase the resolution of an object of interest.

See also

Elham Mahamid Ruzin (born 19901), Israeli Paralympic goalball player The Island of the Colorblind, a book describing prevalent achromatopsia due to the founder effect. Achromatopsia at MedicineNet Achromatopsia at Merriam-Webster Achromatopsia at NCBI The Achromatopsia Network – an archive of information about Achromatopsia and advice on coping with the condition.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1372336575 under CC BY-SA 4.0; modifications have been made.

References

  1. ↩Wikipedia “achromatopsia” revision 1372336575 · retrieved 2026-10-20 date of birth (×1) · confidence 0.95 revision URL